Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Phase II evaluation of rubidazone (NSC-164011) in advanced carcinoma of the breast - A Southwest Oncology Group study
Investigational New Drugs, Volume 1, No. 4, Year 1983
Notification
URL copied to clipboard!
Description
The SWOG carried out a Phase II evaluation of rubidazone in patients with advanced breast cancer. Good risk patients were given rubidazone 150 mg/m2 IV every three weeks. Poor risk patients were given a 25% dose reduction at the start of treatment. Rubidazone dose was increased or decreased depending on toxicity. One patient went into complete remission, four had partial remission and nine had stable disease. Forty-two patients showed increased disease on treatment. No cardiotoxicity was seen, but other common toxicities noted included mostly mild to moderate myelosuppression, nausea, vomiting and alopecia. This study failed to indicate significant antitumor activity of rubidazone in patients with advanced breast carcinoma. © 1983 Martinus Nijhoff Publishers.
Authors & Co-Authors
Smith, Frank E.
United States, Houston
Baylor College of Medicine
Gad-El-Mawla, Nazli M.
Egypt, Giza
National Cancer Institute
Tranum, Bill L.
United States, Little Rock
University of Arkansas for Medical Sciences
Baker, Laurence H.
United States, Detroit
Wayne State University School of Medicine
Panettiere, Frank J.
United States, Little Rock
University of Arkansas for Medical Sciences
Athens, John
United States, Salt Lake City
University of Utah Health Sciences
Foulkes, Mary
United States, Houston
Southwest Oncology Group
Statistics
Citations: 7
Authors: 7
Affiliations: 6
Identifiers
Doi:
10.1007/BF00177415
ISSN:
01676997
e-ISSN:
15730646
Research Areas
Cancer
Health System And Policy